These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22096900)

  • 1. [Mechanism of HCV persistence].
    Hiroishi K; Ishii S; Imawari M
    Nihon Rinsho; 2011 May; 69 Suppl 4():92-6. PubMed ID: 22096900
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV immunopathogenesis: virus-induced strategies against host immunity.
    Szabo G; Dolganiuc A
    Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
    Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
    Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence.
    Ryan EJ; O'Farrelly C
    J Viral Hepat; 2011 Sep; 18(9):601-7. PubMed ID: 21794024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection.
    Rodrigue-Gervais IG; Rigsby H; Jouan L; Sauvé D; Sékaly RP; Willems B; Lamarre D
    J Immunol; 2010 Mar; 184(6):3134-44. PubMed ID: 20173023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunopathogenesis of viral hepatitis].
    Neumann-Haefelin C; Thimme R
    Praxis (Bern 1994); 2007 Apr; 96(14):545-51. PubMed ID: 17455566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.
    Martini F; Sacchi A; Lalle E; Castilletti C; D'Offizi G; Abbate I; Capobianchi MR
    Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology of hepatitis C virus infections.
    Spaan M; Janssen HL; Boonstra A
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):391-400. PubMed ID: 23199499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.
    Salem ML; El-Demellawy M; El-Azm AR
    Cell Immunol; 2010; 262(2):96-104. PubMed ID: 20338549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of the immune surveillance against HCV infection].
    Takaki A; Koike K; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):143-6. PubMed ID: 15359781
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of dendritic cells in the infection by HIV and HCV].
    Belmonte L; Parodi C; Bare P; Baston M; Bracco MM; Ruibal-Ares B
    Medicina (B Aires); 2007; 67(1):63-70. PubMed ID: 17408026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
    Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
    J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection.
    Tsubouchi E; Akbar SM; Horiike N; Onji M
    J Gastroenterol; 2004 Aug; 39(8):754-62. PubMed ID: 15338369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell.
    Agaugué S; Perrin-Cocon L; André P; Lotteau V
    PLoS One; 2007 Mar; 2(3):e330. PubMed ID: 17389921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered innate immunity in chronic hepatitis C infection: cause or effect?
    Szabo G; Chang S; Dolganiuc A
    Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.